Neuropeptide Y receptor subtype Y5 antagonists (Lundbeck)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNeuropeptide Y receptor subtype Y5 antagonists (Lundbeck)
Drug Alias Nameindolyl and dihydroindolyl glycinamides (H Lundbeck)NPY5 antagonists (Lundbeck)LU-AE00654LU-AA33810
ClassificationSmall molecules
Mechanisms of ActionNeuropeptide Y receptor type 5 antagonistsAppetite suppressant
TargetsNeuropeptide Y receptor type 5
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesH. Lundbeck A/S
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A